A cross-sectional e-survey to map clinical practice of electrocardiogram use as a screening tool in outpatient department: India office electrocardiogram e-survey


  • Divyanshu Prajapati Medical Affairs, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Hiren Prajapati Medical Affairs, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Vijay Joshi Medical Affairs, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Ronak Patel Marketing, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Khushbu Patel Marketing, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Ashish Mishra Marketing, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Nehal Shah Marketing, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India
  • Marmik Bhavsar Marketing, Eris Lifesciences Ltd., Ahmedabad, Gujarat, India




Arrhythmias, ECG abnormalities, Portable handheld ECG, Screening


Background: Early detection of electrocardiogram (ECG) abnormalities in high risk cardiovascular patients with routine ECG screening is the need of the hour. The aim of the e-survey was to understand the use of ECG in high risk cardio-metabolically deranged patients at outpatient departments (OPDs) by Indian physicians.

Methods: A cross-sectional India office ECG (IOECG) e-survey was conducted using Google form questionnaire from November 2021 to December 2021 among Indian physicians. Survey results were collected and analysed using Google form survey tool.

Results: We received total of 1863 responses. The results of the survey showed that while 90% of physicians agreed to the necessity of doing 12 lead ECG of cardio-metabolically deranged patients, only 61% of all physicians could perform ECG screening in less than 40% of high risk cardio-metabolic patients mainly, due to several practical challenges. Among physicians, 40.2% physicians believed that 12 lead ECG was too time consuming, 35.8% physicians believed that the unavailability of ECG device was common reason while 27.5% physicians believed that there was a lack of trained staff. Majority of physicians (69.7%) agreed to use point of care ECG device which can be a solution for more screening of such patients whether symptomatic or asymptomatic. According to the survey, 88.7% physicians would appreciate if a portable handheld ECG device was made available to facilitate screening in their practice.

Conclusions: There is a need of the portable handheld ECG device which helps physicians to screen large number of cardio-metabolically deranged patients in their busy OPDs.


Zhao D. Epidemiology of cardiovascular diseases in Asia. JACC. 2021;1(1):1-13.

Prabhakaran D, Jeemon P, Roy A. Cardiovascular diseases in India. Circulation. 2016;133(16):1605-20.

Kumar SA, Sinha N, Cardiovascular disease in India: A 360 degree overview. Med J Armed Force India. 2020;76:1-3.

Zannad F. Cardiovascular high-risk patients-treat to protect, but whom? Medscape J Med. 2008;10(2):1-13.

ADA 2022. Cardiovascular disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(1):144-74.

Loannou A, Papageorgiou N, Singer D, Missouris CG. Registry report of the prevalence of ECG abnormalities and their relation to patient characteristics in an asymptomatic population. Int J Med. 2018;111(12):875-9.

Auer R, Bauer DC, Marques-Vidal P, Butler J, Min LJ, Cornuz J, et al. Association of major and minor ecg abnormalities with coronary heart disease events. JAMA. 2012;307(14):1497-505.

Shah K, Pandya A, Kotwani P, Saha S, Desai C, Tyagi K, et al. S. Cost-effectiveness of portable electrocardiogram for screening cardiovascular diseases at a primary health center in Ahmedabad District, India. Front Public Health. 2021;9:753443.

Rosiek A, Leksowski K. The risk factors and prevention of cardiovascular disease: the importance of electrocardiogram in the diagnosis and treatment of acute coronary syndrome. Therapeut Clin Risk Manage. 2016;1:1223-9.

Zwartkruisa VW, Groenewegenb A, Ruttenb FH, Hollanderb M, Hoesb AW, Endea M, et al. Proactive screening for symptoms: a simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study. Prevent Med. 2020;138:106143.

Krittayaphong R, Muenkaew M, Chiewvit P, Ratanasit N, Kaolawanich Y, Phrommintiku A. Electrocardiographic predictors of cardiovascular events in patients at high cardiovascular risk: a multicenter study. J Geriatr Cardiol. 2019;16:630-8.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227-337.

Azram M, Ahmed N, Leese L, Brigham M, Bowes R, Wheatcroft SB, et al. Clinical validation and evaluation of a novel six lead handheld electrocardiogram recorder compared to the 12-lead electrocardiogram in unselected cardiology patients (EVALECG Cardio). Eur Heart J Digital Health. 2021.

Krzowski B, Skoczylas K, Osak G, Zurawska N, Peller M, Kołtowski L, et al. Kardia Mobile and ISTEL HR applicability in clinical practice: a comparison of Kardia Mobile, ISTEL HR, and standard 12-lead electrocardiogram records in 98 consecutive patients of a tertiary cardiovascular care centre. Eur Heart J Digital Health. 2021;2:467-9.

Kleiman R, Darpo B, Brown R, Rudo T, Chamoun S, Albert DE, et al. Comparison of electrocardiograms (ECG) waveforms and centralized ECG measurements between a simple 6-lead mobile ECG device and a standard 12-lead ECG. Ann Noninvasive Electrocardiol. 2021;26:12872.






Original Research Articles